Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Alembic Pharmaceuticals Limited ( (IN:APLLTD) ).
Alembic Pharmaceuticals Limited held its 15th Annual General Meeting on August 5, 2025, via video conferencing, adhering to the regulations set by the Companies Act, 2013, and SEBI Listing Regulations, 2015. The meeting, attended by all directors and key auditors, facilitated electronic voting for resolutions and included a statement from the Chairman & CEO, Mr. Chirayu Amin, who addressed company affairs and responded to member inquiries.
More about Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of pharmaceutical products. The company is known for its extensive range of generic formulations and active pharmaceutical ingredients, serving both domestic and international markets.
Average Trading Volume: 29,210
Technical Sentiment Signal: Strong Buy
Current Market Cap: 188.3B INR
See more data about APLLTD stock on TipRanks’ Stock Analysis page.